← Open Payments lookup

MATTHEW BOYTE: Open Payments

NPI 1366949133 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,647 in 82 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $1,647

Food & beverage: $1,647
CompanyPaymentsAmount
ABBVIE INC.18$281
Alkermes, Inc.11$274
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$263
Vanda Pharmaceuticals Inc.7$156
Otsuka America Pharmaceutical, Inc.7$139
E.R. Squibb & Sons, L.L.C.6$115
Corium, LLC6$99
Alpha Cognition USA, Inc.1$92
Neurocrine BioSciences, Inc.2$60
Lundbeck LLC3$57

Products named: VRAYLAR, ARISTADA, CAPLYTA, FANAPT, REXULTI, COBENFY, Azstarys, Zunveyl.

Industry payments across AL — which companies pay providers there.